Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR's share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$14.19 and traded as low as C$12.93. Cipher Pharmaceuticals shares last traded at C$13.05, with a volume of 33,908 shares traded.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus lowered their price target on shares of Cipher Pharmaceuticals from C$19.00 to C$17.00 in a report on Monday, November 11th.
View Our Latest Report on CPH
Cipher Pharmaceuticals Stock Performance
The stock has a market capitalization of C$231.60 million, a PE ratio of 14.25 and a beta of 1.20. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. The business's fifty day moving average price is C$14.07 and its 200-day moving average price is C$14.98.
About Cipher Pharmaceuticals
(
Get Free Report)
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
Further Reading
Before you consider Cipher Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cipher Pharmaceuticals wasn't on the list.
While Cipher Pharmaceuticals currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
